BeiGene Ltd (BGNE)
161.02
-7.59
(-4.50%)
USD |
NASDAQ |
May 10, 16:00
161.02
0.00 (0.00%)
After-Hours: 20:00
BeiGene Cash from Financing (Quarterly): 162.29M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 162.29M |
| December 31, 2023 | 347.05M |
| September 30, 2023 | -76.78M |
| June 30, 2023 | 166.08M |
| March 31, 2023 | -19.87M |
| December 31, 2022 | -110.37M |
| September 30, 2022 | 120.24M |
| June 30, 2022 | -17.58M |
| March 31, 2022 | -11.27M |
| December 31, 2021 | 3.385B |
| September 30, 2021 | 109.21M |
| June 30, 2021 | 35.63M |
| March 31, 2021 | 107.42M |
| December 31, 2020 | 325.66M |
| September 30, 2020 | 1.994B |
| June 30, 2020 | 80.99M |
| March 31, 2020 | 2.802B |
| December 31, 2019 | 2.198M |
| September 30, 2019 | 25.14M |
| Date | Value |
|---|---|
| June 30, 2019 | 15.38M |
| March 31, 2019 | 42.96M |
| December 31, 2018 | 8.803M |
| September 30, 2018 | 871.25M |
| June 30, 2018 | 46.58M |
| March 31, 2018 | 763.90M |
| December 31, 2017 | 3.048M |
| September 30, 2017 | 339.71M |
| June 30, 2017 | 145.07M |
| March 31, 2017 | 2.533M |
| December 31, 2016 | 198.69M |
| September 30, 2016 | 7.64M |
| June 30, 2016 | 4.521M |
| March 31, 2016 | 170.05M |
| December 31, 2015 | -0.119M |
| September 30, 2015 | 6.371M |
| June 30, 2015 | 96.95M |
| March 31, 2015 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-110.37M
Minimum
Dec 2022
3.385B
Maximum
Dec 2021
472.11M
Average
94.21M
Median
Cash from Financing (Quarterly) Benchmarks
| Theravance Biopharma Inc | -30.61M |
| LumiraDx Ltd | -14.78M |
| Dr Reddy's Laboratories Ltd | -6.664M |
| ASLAN Pharmaceuticals Ltd | -- |
| Zai Lab Ltd | 47.55M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -308.57M |
| Cash from Investing (Quarterly) | -209.83M |
| Free Cash Flow | -1.566B |
| Free Cash Flow Per Share (Quarterly) | -4.811 |
| Free Cash Flow to Equity (Quarterly) | -641.63M |
| Free Cash Flow to Firm (Quarterly) | -501.62M |
| Free Cash Flow Yield | -9.26% |